Category: Uncategorized

With COVID-19 continuing to impact the lives of people across the world, research is vital to combat this virus. In hopes of finding an antidote, the University of Alberta and University of Calgary have partnered up to lead an investigation to see if the drug hydroxychloroquine (HCQ) may be effective in treating COVID-19. This week, […]

Read More… from ALBERTA HOPE COVID-19 TRIAL LAUNCHES

This is a global, multicenter clinical trial to test the effectiveness and safety of an investigational drug called Relamorelin for the treatment of gastroparesis in people who also have diabetes mellitus. An investigational drug is a drug that is not for sale in this country. This is a 16 week long, placebo-controlled, double-blinded study. There […]

Read More… from Diabetic Gastroparesis Treatment Study Seeks Participants

SCORED Clinical Trial* The University of Calgary Clinical Trials Unit is currently seeking individuals with Type 2 Diabetes to participate in this clinical trial. This study investigates a new type of glucose-lowering drug that works in the kidneys to allow more sugar to be lost in the urine and intestines to prevent absorption of sugars. […]

Read More… from Type 2 Diabetics Needed for a Clinical Trial Investigating a New Type of Glucose-Lowering Drug

The University of Calgary Clinical Trials Unit, at The Diabetes Hypertension and Cholesterol Center, is currently seeking individuals with Type 2 Diabetes to participate in a clinical trial called the REMIT Study. This trial is researching the effectiveness of a new approach to diabetes treatment, with the intention of inducing a remission of diabetes. This […]

Read More… from Seeking Individuals with Type 2 Diabetes for the REMIT Study (Lifestyle Intervention)

Have you ever wondered how the foods you eat and the bacteria in your gut impact your thoughts and behaviours? A study at the University of Calgary is working to explore just that. Individuals ages 12-17 are being sought for a study comparing nutritional and microbiota differences between youth with obsessive-compulsive disorder (OCD) and without […]

Read More… from A study in youth aged 12–17 is studying the effects of gut bacteria on thoughts and behaviours

Currently, there are many medications for adult depression but very few medications for children and young people. KITES, an ADVANCE study, is an international clinical research study that will evaluate the safety and efficacy of an investigational drug in treating depression in children and youth aged 7–17. If your child or teenager has been diagnosed […]

Read More… from Study for children and youth aged 7–17 with major depressive disorder

Older adults are the fastest growing group in the Alberta population. Within 20 years, one in five Albertans will be 65 years of age or older.  Given our aging population, seniors’ health is an important issue for the healthcare system and Albertans. Seniors’ health covers a wide breadth of topics, and research studies contribute to […]

Read More… from Survey Opportunity: Shaping Senior’s Health Research by Letting Us Know What Matters to You

Our FYBER research group at the U of A is looking for research participants to help with our new and innovative gut bacteria and fibre study. We are interested in seeing how a dietary fibre supplement will impact our health through improving the health of our gut microbes. We will ask you to add a […]

Read More… from Research Participants Needed to Help with Novel Fiber and Gut Bacteria Study!

When you live with a chronic disease, bills from costly medications can add up. Investigators from the University of Calgary want to see this change and created the ACCESS Trial as a result. The purpose of the ACCESS Trial is to determine whether providing selected high-value preventive medications and comprehensive patient education programs for free […]

Read More… from ACCESS Trial aims to improve the health of low-income seniors